These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1544866)
1. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Hiyoshi H; Matsuno Y; Kato H; Shimosato Y; Hirohashi S Jpn J Cancer Res; 1992 Jan; 83(1):101-6. PubMed ID: 1544866 [TBL] [Abstract][Full Text] [Related]
2. [p53 alterations in human lung cancer and their correlation with clinicopathological features and prognosis]. Zhang J; Zheng J; Fang W Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):286-9. PubMed ID: 11244999 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
5. High incidence of nuclear accumulation of p53 protein in gastric cancer. Uchino S; Noguchi M; Hirota T; Itabashi M; Saito T; Kobayashi M; Hirohashi S Jpn J Clin Oncol; 1992 Aug; 22(4):225-31. PubMed ID: 1279244 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma. Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770 [TBL] [Abstract][Full Text] [Related]
8. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937 [TBL] [Abstract][Full Text] [Related]
9. Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes. Konishi T; Lin Z; Fujino S; Kato H; Mori A Hum Pathol; 1997 May; 28(5):544-8. PubMed ID: 9158702 [TBL] [Abstract][Full Text] [Related]
10. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Shimaya K; Shiozaki H; Inoue M; Tahara H; Monden T; Shimano T; Mori T Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):271-6. PubMed ID: 8506620 [TBL] [Abstract][Full Text] [Related]
11. [Detection of the p53 protein accumulation and p53 gene mutation in squamous cell carcinoma of the lung]. Li S; Liu H; Wang D Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):123-6. PubMed ID: 11244963 [TBL] [Abstract][Full Text] [Related]
12. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965 [TBL] [Abstract][Full Text] [Related]
13. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma. Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652 [TBL] [Abstract][Full Text] [Related]
14. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237 [TBL] [Abstract][Full Text] [Related]
16. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497 [TBL] [Abstract][Full Text] [Related]
17. p53 expression in non small cell lung cancer: clinical and biological correlations. Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of mutant p53 protein expression in lung adenocarcinoma]. Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):23-8. PubMed ID: 25603869 [TBL] [Abstract][Full Text] [Related]
19. Expression and significance of tumoral suppressor p53 gene in lung adenocarcinomas. Cornianu M; Tudose N; Potencz E; Lazăr E Rom J Morphol Embryol; 1996; 42(1-2):73-82. PubMed ID: 9038389 [TBL] [Abstract][Full Text] [Related]
20. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer. Cai S; Han K J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]